Literature DB >> 9434776

Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma.

C C Hsia1, Y Nakashima, E Tabor.   

Abstract

Two patients with hepatocellular carcinoma (HCC) were identified who had substantial deletions within the hepatitis B virus (HBV) X gene from HCC tissues. In one patient, the deletion was found at nt. 382-389 (codons 128-130) of the X gene, followed by two nucleotide substitutions, a frame shift, and formation of a new stop codon. In the second patients, the deletion was found at nt. 389-396 (codons 130-132) of the X gene, followed by one nucleotide substitution, a frame shift, and formation of a new stop codon. The resulting X proteins in both cases would be truncated at the 3' end and would be 20 amino acids shorter than the full length X protein. These patients had been identified during a study of 25 HCC patients from Qidong, China in whom a 228-base region of the X gene was sequenced. No deletions were found within this X gene sequence in HCC tissues from the other 23 patients or in the 20 adjacent noncancerous liver samples available from these patients. However, the fact that these deletions encompassed codons 130 and 131, two adjacent codons where point mutations were found in 21 of the remaining 23 patients, suggests that this region may play an important role in hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9434776     DOI: 10.1006/bbrc.1997.7882

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Hepatitis B virus X gene and hepatocarcinogenesis.

Authors:  Sue-Ann Ng; Caroline Lee
Journal:  J Gastroenterol       Date:  2011-06-08       Impact factor: 7.527

Review 2.  Hepatitis B virus and hepatocellular carcinoma.

Authors:  P Arbuthnot; M Kew
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

Review 3.  Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.

Authors:  Ashraf Ali; Hany Abdel-Hafiz; Mohd Suhail; Amany Al-Mars; Mohammad Khalid Zakaria; Kaneez Fatima; Sultan Ahmad; Esam Azhar; Adeel Chaudhary; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

4.  Expression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus.

Authors:  S P Guo; W L Wang; Y Q Zhai; Y L Zhao
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

5.  The C-terminal region of the hepatitis B virus X protein is essential for its stability and function.

Authors:  Rebecca A Lizzano; Bei Yang; Amy J Clippinger; Michael J Bouchard
Journal:  Virus Res       Date:  2010-10-20       Impact factor: 3.303

6.  Activating mechanism of transcriptor NF-kappaB regulated by hepatitis B virus X protein in hepatocellular carcinoma.

Authors:  Tao Wang; Yi Wang; Meng-Chao Wu; Xin-Yuan Guan; Zheng-Feng Yin
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

7.  COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma.

Authors:  Xiao-Hong Liu; Jing Lin; Shu-Hui Zhang; Shun-Min Zhang; Mark-A Feitelson; Heng-Jun Gao; Ming-Hua Zhu
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

8.  C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.

Authors:  Rachel Hiu Ha Ching; Karen Man Fong Sze; Eunice Yuen Ting Lau; Yung-Tuen Chiu; Joyce Man Fong Lee; Irene Oi Lin Ng; Terence Kin Wah Lee
Journal:  Oncotarget       Date:  2017-04-04

9.  Carboxyl-terminal truncated HBx contributes to invasion and metastasis via deregulating metastasis suppressors in hepatocellular carcinoma.

Authors:  Weihua Li; Man Li; Dongjiang Liao; Xinpeng Lu; Xia Gu; Qianqian Zhang; Zhixiang Zhang; Hui Li
Journal:  Oncotarget       Date:  2016-08-23

10.  Identification of transforming hepatitis B virus S gene nonsense mutations derived from freely replicative viruses in hepatocellular carcinoma.

Authors:  Shiu-Feng Huang; Ya-Ting Chen; Wei-Chen Lee; Il-Chi Chang; Yu-Ting Chiu; Yu Chang; Hsiao-Chen Tu; Chiou-Hwa Yuh; Isao Matsuura; Liang-Yu Shih; Ming-Wei Lai; Hong-Dar Isaac Wu; Miin-Fu Chen; Chau-Ting Yeh
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.